| Mrs Sarah E Dziwanowski, LCSW-C | |
|
312 Robert Price Ct, Glen Burnie, MD 21060-8581 | |
| (240) 447-3296 | |
| Not Available |
| Full Name | Mrs Sarah E Dziwanowski |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 312 Robert Price Ct, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689263188 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 20601 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sarah E Dziwanowski, LCSW-C 312 Robert Price Ct, Glen Burnie, MD 21060-8581 Ph: (240) 447-3296 | Mrs Sarah E Dziwanowski, LCSW-C 312 Robert Price Ct, Glen Burnie, MD 21060-8581 Ph: (240) 447-3296 |
News Archive
Compared with women, American men have worse access to reproductive and sexual health care, research shows, a disparity fueled in part by the lack of standard clinical guidelines on the types and timing of exams, tests and treatments that should be offered to all men of reproductive age.
The immune system actually wants to fight SARS-CoV-2 with antiviral signaling molecules. But a research team from Charité and MDC has now shown how such a signaling molecule can promote the replication of the virus. The results have been published in the journal EMBO Molecular Medicine.
The shortage of personal protective equipment (PPE) available to healthcare professionals has become increasingly problematic as Covid-19 cases continue to surge.
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.
› Verified 2 days ago
Deadra Carnack Atkins, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Rd N, Suite A, Glen Burnie, MD 21060 Phone: 410-222-6785 | |
David A Nunez, LMSW, CAC-AD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 102 6th Ave Ne Ste B, Glen Burnie, MD 21060 Phone: 410-320-9967 Fax: 443-835-3925 | |
Ashley Nicole Palestis, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Rd N Ste A, Glen Burnie, MD 21060 Phone: 410-222-6785 | |
Janet Silber, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 30 Greenway St Nw Ste 5, Glen Burnie, MD 21061 Phone: 410-760-9079 | |
Vicki Fearey, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7310 Ritchie Highway, Suite 1009, Glen Burnie, MD 21061 Phone: 410-768-5988 | |
Kelly Hoenshell, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 217 Allen Rd, Glen Burnie, MD 21061 Phone: 443-557-8730 | |
Kristilee P Sheffler, LGSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 804 Landmark Dr, Suite 118, Glen Burnie, MD 21061 Phone: 410-863-7213 Fax: 410-863-7205 |